SAVA - Nasdaq Dips 300 Points; Johnson & Johnson Earnings Top Estimates | Benzinga
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling around 300 points on Wednesday.
Following the market opening Wednesday, the Dow traded down 0.10% to 40,914.80 while the NASDAQ fell 1.63% to 18,208.05. The S&P 500 also fell, dropping, 0.98% to 5,611.77 .
Check This Out: Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday
Leading and Lagging Sectors
Energy shares jumped by 0.5% on Wednesday.
In trading on Wednesday, information technology shares fell by 2.3%.
Top Headline
Johnson & Johnson (NYSE:JNJ) reported better-than-expected second-quarter earnings on Wednesday.
The company posted adjusted EPS of $2.82, up 10.2% year-over-year, beating the consensus of $2.70. The pharma giant reported sales of $22.45 billion, up 4.3% year-over-year, beating the consensus of $22.31 billion.
Johnson & Johnson raised fiscal year 2024 operational sales guidance to $89.2 billion-$89.6 billion versus prior guidance of $88.7 billion-$89.1 billion.
Equities Trading UP
- Aditxt, Inc. (NASDAQ:ADTX) shares shot up 67% to $2.66. Aditxt and Evofem amended merger ...